NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
Back to search
Official data from USPTO
AVID RADIOPHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVID RADIOPHARMACEUTICALS
ST13
US500000097360821Class
5
Filing
97360821
Registration
7014191
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
03/28/2023
Trademark type
Word
Nice classes
5
Filing date
04/15/2022
Registration date
03/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/25/2022
First use in commerce
10/25/2022
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
MCCUTCHEON, RICHARD
Law office
T70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Avid Radiopharmaceuticals, Inc.
Representatives
Bruce W. Longbottom ELI LILLY AND COMPANY
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic agentspreparations and substances containing radioactive agents for medical purposes; radioactive diagnostic scanning agents for in vivo use for detection and monitoring of beta-amyloid plaque; radiopharmaceutical preparations for clinicalmedical and research use for diagnosing and treating brain diseases and disorders in the field of brain plaque density; radioactive pharmaceutical preparations and non-radioactive medical reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use for diagnosing and treating brain diseases and disorders; radiopharmaceutical preparations for use in diagnosis of Alzheimer's disease
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/18/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/17/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/08/2023
IUAF
USE AMENDMENT FILED
01/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
01/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2022
PUBO
PUBLISHED FOR OPPOSITION
07/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/22/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/22/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/22/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/22/2022
DOCK
ASSIGNED TO EXAMINER
06/17/2022
DOCK
ASSIGNED TO EXAMINER
06/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2022
NWAP
NEW APPLICATION ENTERED
04/19/2022
Continuous trademark protection
Get notified about every new filing that threatens AVID RADIOPHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.